In search of a biological pattern for human longevity: Impact of apo A- IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 407-417

  Pepe, G ^a   Di Perna, V ^a   Resta, F ^a   Lovecchio, M ^a   Chimienti, G ^a   Colacicco, A M ^a   Capurso, A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Aging; Allele variants; Apo A IV; Apo(a); Haplotype; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN;

AGED; AGING; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; LONGEVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS A; DNA; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS; LONGEVITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0032055034     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00290-6     Document Type: Article

References (43)

1. Franceschi C. Cell proliferation, cell death and aging. Aging. 1:1989;3-15.
2. Takata H., Ishii T., Suzuki M., Sekiguchi S., Iri H. Influence of major histocompatibility complex region genes on human longevity among Okinawan-Japanese centenarians and nonagenarians. Lancet. ii:1987;824-826.
3. Louhija J., Miettinen HE., Kontula K., Tikkanen M.J., Miettinen T.A., Tilvis R.S. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb. 14:1994;1084-1089.
4. De Benedictis G., Falcone E., Rose G., Ruffolo R., Spadafora P., Baggio G., Bertolini S., Mari M., Mattace R., Monti D., Morellini M., Sansoni P., Franceschi C. DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus. Hum Genet. 99:1997;312-318.
5. Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic association with human longevity at the apo E and ACE loci. Nat Genet. 6:1995;29-32.
6. Ehnholm C., Tenkanen H., de Knijff P., Havekes L., Rosseneu M., Menzel H.J., Tiret L. On behalf of the EARS Group. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: The EARS study. Atherosclerosis. 107:1994;229-238.
7. Sandholzer C., Saha N., Kark J.D., Rees A., Jarross W., Dieplinger H., Hoppichler F., Boerwinkle E., Utermann G. Apo(a) isoforms predict risk for coronary heart disease: A study in six populations. Arterioscler Thromb. 12:1992;1214-1226.
8. Sandkamp M., Funke H., Schulte H., Kohler E., Assmann G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem. 36:1990;20-23.
9. Karathanasis S.K., Oettgen P., Addad I.A., Antonarakis S.E. Structure evolution and polymorphisms of the human apolipoprotein A4 gene. Proc Natl Acad Sci USA. 83:1986;8457-8461.
10. Elshourbagy N.A., Walker D.W., Paik Y.K., Boguski M.S., Freeman M., Gordon J.I., Taylor J.M. Structure and expression of the human apolipoprotein A-IV gene. J Biol Chem. 262:1987;7973-7981.
11. Yang C.Y., Gu Z.W., Chong I., Xiong W., Rosseneu M., Yang K.X., Gotto A.M. Jr., Chan L. The primary structure of human apolipoprotein A-IV. Biochem Biophys Acta. 1002:1989;231-237.
12. Lohse P., Kindt M.R., Rader D.J. Jr., Brewer H.B. Three genetic variants of human plasma apolipoprotein apo A-IV. J Biol Chem. 21:1991;13513-13518.
13. Tenkanen H., Ehnholm C. Molecular biology of apolipoprotein A-IV. Curr Opin Lipidol. 4:1993;95-99.
14. Lohse P., Brewer B. Jr. Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipidol. 2:1991;90-95.
15. Kamboh M.I., Friedlaender J.S., Ahn Y.I., Ferrell R.E. A common deletion polymorphism in the apolipoprotein A4 gene and its significance in lipid metabolism. Arterioscler Thromb. 14:1994;656-662.
16. von Eckardstein A., Funke H., Schulte M., Erren M., Schulte H., Assmann G. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet. 50:1992;1115-1128.
17. von Eckardstein A., Heinrich J., Funke H., Schulte H., Schönfeld R., Köhler E., Steinmetz A., Assmann G. Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of Lipoprotein(a) and fibrin split products in coronary heart disease patients. Arterioscler Thromb. 13:1993;240-246.
18. Eichner JE., Kuller L.H., Ferrell R.E., Kamboh M.I. Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol. 6:1989;493-499.
19. Menzel H.J., Sigurdsson G., Boerwinkle E., Schrangl-Will S., Dieplinger H., Utermann G. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet. 84:1990;344-346.
20. McCombs R.J., Marcadis D.E., Ellis J., Weinberg R.B. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. New Engl J Med. 11:1994;706-710.
21. Wade D.P. Lipoprotein(a). Curr Opin Lipidol. 4:1993;244-249.
22. Utermann G. The mysteries of lipoprotein(a). Science. 246:1989;904-910.
23. Mc Lean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless A.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 300:1987;132-137.
24. Utermann G., Haibach C., Trommsdorff M., Köchl S., Abe A., Kraft H.G. Genetic architecture of the atherogenic Lipoprotein(a). Ann New York Acad Sci. 748:1995;301-312.
25. Gaw A., Hobbs H.H. Molecular genetics of lipoprotein(a): New pieces to the puzzle. Curr Opin Lipidol. 5:1994;145-155.
26. Scanu AM., Fless G.M. Lipoprotein(a): Heterogeneity and biological relevance. J Clin Invest. 85:1990;1709-1715.
27. Jenner J.L., Ordovas J.M., Lamon-Fava S., Schaefer M.M., Wilson P.W.F., Castelli W.P., Schaefer E.J. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels. The Framingham offspring study. Circulation. 87:1993;1135-1141.
28. Utermann G., Kraft H.G., Menzel H.J., Hopferwieser T., Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet. 78:1988;41-46.
29. Zenker G., Koltringer P., Boné G., Niederkorn K., Pfeiffer K., Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke. 17:1986;942-945.
30. Motta L, Receputo G, Franceschi C, Capurso A, Resta F. On behalf of the Italian Multicentric Study on Centenarians. I Centenari in Italia: Aspetti Epidemiologici e Clinico-Biologici. 1995. Ed L. Pozzi, Roma.
31. Capurso A., Mogavero A.M., Resta F., Di Tommaso M., Taverniti R., Turturro F., La Rosa M., Marcovina S., Catapano A.L. Apolipoprotein C-II deficiency: Detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients. J Lipid Res. 29:1988;703-711.
32. Friedewald W.T., Levy RI., Fredrickson D.S. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-508.
33. Kronenberg F., Trenkwalder E., Dieplinger H., Utermann G. Lipoprotein (a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol. 16:1996;1568-1572.
34. Higuchi R. Rapid and efficient DNA extraction for PCR from cells or blood. Amplification. 2:1989;2-3 Perkin-Elmer, Minneapolis, KS.
35. Zaiou M., Visvikis S., Visvikis A., Siest G. A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene. J Lipid Res. 33:1992;1061-1066.
36. Utermann G., Menzel H.J., Kraft H.G., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 80:1987;458-465.
37. Nei M. Molecular Evolutionary Genetics. 1987;Columbia University Press, New York.
38. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
39. Krauss RM. Low-density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol. 2:1991;248-252.
40. de Knijff P., Kaptein A., Boomsma D., Princen H.M.G., Frants R.R., Havekes L.M. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). Atherosclerosis. 90:1991;169-174.
41. Mari D., Mannucci P.M., Coppola R., Bottasso B., Bauer K.A., Rosemberg R.D. Hypercoagulability in centenarians: The paradox of successful aging. Blood. 85:1995;3144-3149.
42. Berg K., Ro O.C. Lp(a) lipoprotein level and longevity. Ann Génét. 34:1991;264-269.
43. Zuliani G., Bader G., Imbastaro T., Mezzetti A., Taddeo U., Kostner G.M., Fellin R. Associazione Medica Sabin. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Aging Clin Exp Res. 7:1995;385-391.